Luke M. Beshar, EVP & CFO at NPS PHARMACEUTICALS INC (NPSP), sold 52,258 shares at $35.00 ($1.8M) on 2014-12-17, disclosed to the SEC on 2014-12-19.
Scheduled sale ($1.8M) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TARA | BUY | 2022-03-14 | $45K | — | Filing → |
| RGNX | SELL | 2018-12-03 | $831K | — | Filing → |
| RGNX | SELL | 2018-11-28 | $2.6M | — | Filing → |